Clinical research software and services provider Nextrials will showcase its clinical trial management solution at the annual IHE North America Connectathon, which will be held from 28 January - 2 February 2013 at Hyatt Regency Chicago, US. ...
Tags: clinical trial, Clinical Research Document, Drug Safety Content
Oncology patients with lower income are substantially less likely to take part in clinical trials, it has been suggested. Research published in the January 7th Journal of Clinical Oncology looked at clinical trial participation patterns, ...
Tags: Oncology, patients, lower income, clinical trials
Boston Scientific has treated the first US patient with symptomatic, drug refractory paroxysmal atrial fibrillation in ZERO AF clinical trial of its Blazer Open-Irrigated Temperature Ablation Catheter. The Blazer Open-Irrigated Catheter ...
Aileron Therapeutics has secured the second tranche in its series D financing, meaning the overall total has now reached $42 million (pound 26 million). This payment followed the successful progression of the company's ALRN-5281 lead ...
CardioFocus will complete full patient enrollment in a US pivotal clinical trial of its HeartLight catheter ablation system in 2013. The 350 patient-based trial, which is evaluating and comparing the safety and efficacy of the company's ...
GI Dynamics has a started a US pivotal trial of its non-surgical device, designed to treat patients with obesity and uncontrolled type 2 diabetes. Flexible, tube-shaped EndoBarrier device, which is implanted into the gut, forms a physical ...
Tags: GI Dynamics, EndoBarrier device, diabetes
Covidien has completed enrolling the first patient in SWIFT PRIME trial of its Solitaire FR Revascularisation device, designed to restore blood flow, administer medical therapy as well as retrieve clot in patients with acute ischemic ...
Tags: Covidien, patient, SWIFT PRIME trial
ElectroCore has initiated enrolling patients in a clinical trial of its GammaCore nVNS therapy, designed for preventing chronic migraine. The easy-to-use, non-invasive device, which enables self-administration of therapy, stimulates ...
Medtronic has completed enrolling the first patient in MIRACLE EF clinical trial, designed to evaluate the effectiveness of its Consulta cardiac resynchronization therapy-pacemaker (CRT-P) in treating symptomatic heart failure patients with ...
Tags: Medtronic, MIRACLE EF, trial, CRT-P
Sky Ridge Medical Center in Colorado, US, has initiated the FDA-approved Delcath Systems' expanded access program (EAP) to provide US patients access to second-generation hemofiltration cartridge of Delcath's proprietary chemosaturation ...
Tags: Sky Ridge Medical Cente, US, FDA, Delcath Systems, EAP
Inovia Pharmaceuticals will move its hepatitis C DNA vaccine into a phase 1/11a clinical trial by the end of 2013. The advancement of this work is based on exceptional results of a preclinical study, which showed for the first time that a ...
Tags: Inovia Pharmaceuticals, hepatitis C DNA vaccine, clinical trial, 2013
Abbott has initiated a ABSORB III clinical trial of its drug eluting bioresorbable vascular scaffold (BVS) device, designed for the treatment of coronary artery disease patients. The Absorb device, which includes a multi-link stent ...
Tags: Abbott, ABSORB III clinical trial, drug eluting BVS, treatment
Volition has announced a new collaboration with the Wales Cancer Bank,with the two businesses set to carry out an internal clinical study for the Nucleosomics diagnostic products. At the end of this month,tests will be carried out on ...
Tags: Volition, Wales Cancer Bank, Nucleosomics diagnostic products
Edison Pharmaceuticals has started a phase 2B study, which will investigate new treatments for Friedreich's ataxia. The trial is entitled Safety and Efficacy Study of EPI-743 on Visual Function in Patients with Friedreich's Ataxia. It is ...
Tags: Edison Pharmaceuticals, disease severity, neuromuscular function
EMD Serono, a subsidiary of Merck, and Pfizer have announced the FDA approval of Rebif Rebidose (interferon beta-1a) for the treatment of relapsing forms of multiple sclerosis (MS). Rebif Rebidose was designed as single-use auto-injector ...